LUBAC determines chemotherapy resistance in squamous cell lung cancer

Ruiz, EJ; Diefenbacher, ME; Nelson, JK; Sancho, R; Pucci, F; Chakraborty, A; Moreno, P; Annibaldi, A; Liccardi, G; Encheva, V; Mitter, R; Rosenfeldt, M; Snijders, AP; Meier, P; Calzado, MA; Behrens, A

Behrens, A (reprint author), Francis Crick Inst, Adult Stem Cell Lab, London, England.; Behrens, A (reprint author), Kings Coll London, Fac Life Sci & Med, London, England.

JOURNAL OF EXPERIMENTAL MEDICINE, 2019; 216 (2): 450

Abstract

Lung squamous cell carcinoma (LSCC) and adenocarcinoma (LADC) are the most common lung cancer subtypes. Molecular targeted treatments have improved LA......

Full Text Link